Boule Diagnostics AB (publ) (STO:BOUL)

Market Cap	314.55M
Revenue (ttm)	523.56M
Net Income (ttm)	-316.68M
Shares Out	38.83M
EPS (ttm)	-8.21
PE Ratio	n/a
Forward PE	10.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	241,693
Average Volume	83,685
Open	8.28
Previous Close	8.38
Day's Range	8.04 - 8.28
52-Week Range	6.50 - 11.50
Beta	0.34
RSI	47.66
Earnings Date	Jul 18, 2025

About Boule Diagnostics AB

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1956
• Employees: 200
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BOUL